Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

937 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.
Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, Patsouris ES, Peros G, Horcic M, Tornillo L, Zuber M, Droeser R, Muraro MG, Mengus C, Oertli D, Ferrone S, Terracciano L, Spagnoli GC. Sconocchia G, et al. Among authors: ferrone s. Int J Cancer. 2011 Jun 1;128(11):2663-72. doi: 10.1002/ijc.25609. Epub 2010 Oct 13. Int J Cancer. 2011. PMID: 20715106 Free PMC article.
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.
Arriga R, Caratelli S, Lanzilli G, Ottaviani A, Cenciarelli C, Sconocchia T, Spagnoli GC, Iezzi G, Roselli M, Lauro D, Coppola A, Dotti G, Ferrone S, Sconocchia G. Arriga R, et al. Among authors: ferrone s. Int J Cancer. 2020 May 1;146(9):2531-2538. doi: 10.1002/ijc.32618. Epub 2019 Aug 30. Int J Cancer. 2020. PMID: 31396956 Free PMC article.
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.
Sconocchia G, Eppenberger-Castori S, Zlobec I, Karamitopoulou E, Arriga R, Coppola A, Caratelli S, Spagnoli GC, Lauro D, Lugli A, Han J, Iezzi G, Ferrone C, Ferlosio A, Tornillo L, Droeser R, Rossi P, Attanasio A, Ferrone S, Terracciano L. Sconocchia G, et al. Among authors: ferrone c, ferrone s. Neoplasia. 2014 Jan;16(1):31-42. doi: 10.1593/neo.131568. Neoplasia. 2014. PMID: 24563618 Free PMC article.
NK cells and T cells cooperate during the clinical course of colorectal cancer.
Sconocchia G, Eppenberger S, Spagnoli GC, Tornillo L, Droeser R, Caratelli S, Ferrelli F, Coppola A, Arriga R, Lauro D, Iezzi G, Terracciano L, Ferrone S. Sconocchia G, et al. Among authors: ferrone s. Oncoimmunology. 2014 Aug 3;3(8):e952197. doi: 10.4161/21624011.2014.952197. eCollection 2014. Oncoimmunology. 2014. PMID: 25610741 Free PMC article.
Melanoma cells inhibit NK cell functions.
Sconocchia G, Arriga R, Tornillo L, Terracciano L, Ferrone S, Spagnoli GC. Sconocchia G, et al. Among authors: ferrone s. Cancer Res. 2012 Oct 15;72(20):5428-9; author reply 5430. doi: 10.1158/0008-5472.CAN-12-1181. Epub 2012 Oct 9. Cancer Res. 2012. PMID: 23047870 No abstract available.
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab.
Caratelli S, Arriga R, Sconocchia T, Ottaviani A, Lanzilli G, Pastore D, Cenciarelli C, Venditti A, Del Principe MI, Lauro D, Landoni E, Du H, Savoldo B, Ferrone S, Dotti G, Sconocchia G. Caratelli S, et al. Among authors: ferrone s. Int J Cancer. 2020 Jan 1;146(1):236-247. doi: 10.1002/ijc.32663. Epub 2019 Oct 12. Int J Cancer. 2020. PMID: 31479522 Free PMC article.
Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage.
Arriga R, Caratelli S, Coppola A, Spagnoli GC, Venditti A, Amadori S, Lanzilli G, Lauro D, Palomba P, Sconocchia T, Del Principe MI, Maurillo L, Buccisano F, Capuani B, Ferrone S, Sconocchia G. Arriga R, et al. Among authors: ferrone s. Oncotarget. 2016 Jan 12;7(2):2070-9. doi: 10.18632/oncotarget.6529. Oncotarget. 2016. PMID: 26655503 Free PMC article.
937 results